Show simple item record

Reduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5

dc.contributor.authorPozzilli, Pen_US
dc.contributor.authorLeslie, RDen_US
dc.contributor.authorPeters, Aen_US
dc.contributor.authorBuzzetti, Ren_US
dc.contributor.authorShankar, SSen_US
dc.contributor.authorMilicevic, Zen_US
dc.contributor.authorPavo, Ien_US
dc.contributor.authorLebrec, Jen_US
dc.contributor.authorMartin, Sen_US
dc.contributor.authorSchloot, Nen_US
dc.date.accessioned2020-09-08T13:04:38Z
dc.date.issued2017en_US
dc.identifier.issn0012-186Xen_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/66861
dc.format.extentS68 - S68en_US
dc.titleReduction of HbA1c with dulaglutide in type 2 diabetes (T2D) patients negative, low positive or high positive for GAD antibodies (GADA): a post hoc analysis of AWARD-2,-4 and-5en_US
dc.typeConference Proceeding
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408315000146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume60en_US
qmul.funderPrevalence and Characterisation of Latent Autoimmune Diabetes in Adults (LADA) across Europe (ACTION LADA)::European Union FP5 European Commission Research Directoratesen_US


Files in this item

Thumbnail
Name:
dom.GLP-1.2018 copy.pdf
Size:
647.6Kb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record